PL1933840T3 - Zastosowanie delmopinolu w leczeniu trądziku - Google Patents

Zastosowanie delmopinolu w leczeniu trądziku

Info

Publication number
PL1933840T3
PL1933840T3 PL06765096T PL06765096T PL1933840T3 PL 1933840 T3 PL1933840 T3 PL 1933840T3 PL 06765096 T PL06765096 T PL 06765096T PL 06765096 T PL06765096 T PL 06765096T PL 1933840 T3 PL1933840 T3 PL 1933840T3
Authority
PL
Poland
Prior art keywords
delmopinol
acne
treatment
Prior art date
Application number
PL06765096T
Other languages
English (en)
Inventor
Jonathan Douglas Lane
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of PL1933840T3 publication Critical patent/PL1933840T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL06765096T 2005-07-22 2006-07-24 Zastosowanie delmopinolu w leczeniu trądziku PL1933840T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0515138.6A GB0515138D0 (en) 2005-07-22 2005-07-22 Acne treatment
EP06765096.0A EP1933840B1 (en) 2005-07-22 2006-07-24 Use of delmopinol in the treatment of acne
PCT/GB2006/002770 WO2007010294A2 (en) 2005-07-22 2006-07-24 Use of delmopinol in the treatment of acne

Publications (1)

Publication Number Publication Date
PL1933840T3 true PL1933840T3 (pl) 2014-03-31

Family

ID=34976444

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06765096T PL1933840T3 (pl) 2005-07-22 2006-07-24 Zastosowanie delmopinolu w leczeniu trądziku

Country Status (17)

Country Link
US (1) US20080269222A1 (pl)
EP (1) EP1933840B1 (pl)
JP (1) JP2009502769A (pl)
KR (2) KR20080038332A (pl)
CN (1) CN101227910A (pl)
AU (1) AU2006271396A1 (pl)
BR (1) BRPI0613749A2 (pl)
CA (1) CA2614846C (pl)
DK (1) DK1933840T3 (pl)
ES (1) ES2439453T3 (pl)
GB (1) GB0515138D0 (pl)
MX (1) MX2008000716A (pl)
NO (1) NO20080816L (pl)
PL (1) PL1933840T3 (pl)
PT (1) PT1933840E (pl)
RU (1) RU2008100220A (pl)
WO (1) WO2007010294A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0502046D0 (en) 2005-02-01 2005-03-09 Sinclair Pharmaceuticals Ltd Method
GB0708960D0 (en) * 2007-05-09 2007-06-20 Sinclair Pharmaceuticals Ltd Method
GB0714338D0 (en) * 2007-07-23 2007-09-05 Sinclair Pharmaceuticals Ltd method
CA3010872A1 (en) 2016-01-11 2017-07-20 Klox Technologies Limited Biophotonic compositions for the treatment of pyoderma
IT201600130538A1 (it) * 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione del delmopinolo
IT201600130642A1 (it) 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione di 2(3 alchilmorfolino)-etan-1-olo
IT201600130729A1 (it) 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione degli intermedi del delmopinolo
IT201700076821A1 (it) * 2017-08-24 2019-02-24 Lundbeck Pharmaceuticals Italy S P A Nuovo sale del delmopinolo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894221A (en) * 1981-03-19 1990-01-16 Ab Ferrosan Method of treating plaque using morpholine compounds
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
DK0510151T3 (da) * 1990-11-09 1995-07-31 Pharmacia Ab Forbedret anti-plak-præparater indeholdende en kombination af morpholinoaminoalkohol og antimikrobielt middel
US20050106111A1 (en) * 2003-09-16 2005-05-19 Aphios Corporation Compositions and methods for reducing dental plaque

Also Published As

Publication number Publication date
EP1933840B1 (en) 2013-11-13
KR20130126746A (ko) 2013-11-20
CN101227910A (zh) 2008-07-23
EP1933840A2 (en) 2008-06-25
RU2008100220A (ru) 2009-08-27
DK1933840T3 (da) 2013-12-02
WO2007010294A3 (en) 2007-03-29
BRPI0613749A2 (pt) 2011-02-08
GB0515138D0 (en) 2005-08-31
MX2008000716A (es) 2008-03-18
CA2614846A1 (en) 2007-01-25
ES2439453T3 (es) 2014-01-23
AU2006271396A1 (en) 2007-01-25
JP2009502769A (ja) 2009-01-29
CA2614846C (en) 2013-12-31
WO2007010294A8 (en) 2008-02-21
PT1933840E (pt) 2013-12-10
WO2007010294A2 (en) 2007-01-25
NO20080816L (no) 2008-02-14
US20080269222A1 (en) 2008-10-30
KR20080038332A (ko) 2008-05-06

Similar Documents

Publication Publication Date Title
HUS1700015I1 (hu) PDGFR-alfa elleni antitest és alkalmazása tumorok kezelésénél
HK1199874A1 (en) Spiro-oxindole compounds and their uses as therapeutic agents
EP1912650B8 (en) Use of flibanserin in the treatment of obesity
IL180078A (en) Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal
IL186615A0 (en) Spiroheterocylic compounds and their uses as therapeutic agents
ZA200803859B (en) Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
IL184356A0 (en) Indoles useful in the treatment of inflammation
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
GB0512940D0 (en) Compounds and their use
PL2101731T3 (pl) Endoksyfen do zastosowania w leczeniu nowotworu
IL185258A (en) Oligodeoxyribonucleotides for use in the treatment of angiogenesis-dependent tumors in human
IL189252A0 (en) Dihydroxyanthraquinones and their use
PL1933840T3 (pl) Zastosowanie delmopinolu w leczeniu trądziku
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
ZA200709542B (en) Combination therapy in the treatment of cancer
IL185575A0 (en) Benzoxazocines and their therapeutic use
GB0505203D0 (en) Skin composition treatment
GB2424794B (en) Improvements in the use of pre-configuration
GB0516610D0 (en) Compounds for use in therapy
HK1125634A1 (en) Pharmaceutical for use in the treatment of ureterolithiasis
GB0503775D0 (en) The compound used in the treatment of HIV
GB0510464D0 (en) Improvements in or relating to medical treatments
GB0505383D0 (en) Diagnosis and treatment
GB0519667D0 (en) Hair treatment device